Crispin Miller

13PUBLICATIONS
147CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersDeep learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 06, 2026
Runx1 and Runx2 act in concert to suppress Wnt/β-catenin-driven mammary tumourigenesis.

|Mar 04, 2026
Vγ1 γδ T cells steer airway macrophages toward a profibrotic response in an autochthonous lung cancer mouse model.

Ximena L Raffo-Iraolagoitia, Amanda J McFarlane, Sarah Laing

|Dec 18, 2025
Nucleophosmin supports WNT-driven hyperproliferation and tumor initiation.

Georgios Kanellos, Chiara Giacomelli, Alexander Raven

|Nov 25, 2025
MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance.

Mark White, Megan L Mills, Laura M Millett

|Nov 19, 2025
Hepatic zonation determines tumorigenic potential of mutant β-catenin.

Alexander Raven, Kathryn Gilroy, Hu Jin

|Oct 28, 2025
PLM-interact: extending protein language models to predict protein-protein interactions.

Dan Liu, Francesca Young, Kieran D Lamb

Pageof 3

Frequent Collaborators

7 joint publications

Colin Nixon

5 joint publications

John Le Quesne

5 joint publications

Robin Shaw

5 joint publications

Owen J Sansom